胰腺导管腺癌及肝转移的检出:钆塞酸二钠增强MR成像与细胞外对比剂比较
回顾性比较272例疑似胰腺疾病患者,钆塞酸二钠增强MR(EOB组79例)与细胞外对比剂增强MR(ECCM组193例)检出胰腺导管腺癌的敏感度(97.1% vs 93.5%,P=0.42)与特异度(100.0% vs 99.2%,P=1.00)无显著差异,但EOB组在逐病灶评估时检出肝转移的敏感度显著更高(95.0% vs 84.5%,P=0.04)。
要点
- EOB组胰腺信号强度比(P<0.001)和肿瘤-胰腺对比噪声比(P=0.0037)显著低于ECCM组。
- EOB与ECCM检出胰腺导管腺癌的敏感度(97.1% vs 93.5%,P=0.42)和特异度(100.0% vs 99.2%,P=1.00)无显著差异。
- 逐病灶评估时EOB组检出肝转移的敏感度显著高于ECCM组(95.0% vs 84.5%,P=0.04)。
关键影像表现/征象
- 测量胰腺实质、椎旁肌、胰腺导管腺癌(如存在)及背景噪声的信号强度,并计算胰腺信号强度比与肿瘤-胰腺对比噪声比。
- 对存在的胰腺导管腺癌,采用动脉优势期图像评估其可见性。
- 对存在的肝转移灶,在所有序列上进行评估。
诊断标准与关键数值
- 钆塞酸二钠组检出胰腺导管腺癌的敏感度为97.1%、特异度为100.0%。
- 细胞外对比剂组检出胰腺导管腺癌的敏感度为93.5%、特异度为99.2%。
- 逐病灶评估时,钆塞酸二钠组检出肝转移的敏感度为95.0%,细胞外对比剂组为84.5%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To compare the detectability of pancreatic ductal adenocarcinoma (PDAC) and liver metastases between Gd-EOB-DTPA- and extracellular contrast materials (ECCMs) contrast-enhanced MR imaging contrast.
METHODS: Two hundred seventy-two patients with suspected pancreatic disease underwent Gd-EOB-DTPA-enhanced MR imaging (EOB group, n = 79) or ECCMs-enhanced MR imaging (ECCM group, n = 193). The ECCM group were administered the following contrast agents: Gd-DTPA (n = 158), Gd-BT-DO3A (n = 28), Gd-DOTA (n = 5), and Gd-DTPA-BMA (n = 2). Signal intensities of pancreatic parenchyma, paraspinal muscle, PDAC (if present), and background noise were measured. The signal intensity ratio (SIR) of the pancreas and tumor-to-pancreas contrast-to-noise ratio (CNR) were also calculated. If present, the conspicuity of PDAC was evaluated with the arterial dominant phase images. Liver metastases, if present, were also evaluated for all sequences. Qualitative and quantitative imaging parameters were compared between EOB and ECCM groups.
RESULTS: SIR of the pancreas (P < 0.001) and CNR (P = 0.0037) were significantly lower in EOB group when compared with the ECCM group. However, the sensitivity (97.1% vs. 93.5%, P = 0.42) and specificity (100.0% vs. 99.2%, P = 1.00) for detecting PDAC were not significant between EOB and ECCM groups. The EOB group showed a significantly greater sensitivity for detecting liver metastases compared with the ECCM group (95.0% vs 84.5%, P = 0.04) when evaluating on a lesion-by-lesion basis.
CONCLUSION: Gd-EOB-DTPA-enhanced MR imaging performed similarly to ECCMs-enhanced MR imaging in detecting PDAC but had better sensitivity in detecting liver metastases.
引用
- Noda Y, Goshima S, Takai Y, et al. Detection of pancreatic ductal adenocarcinoma and liver metastases: comparison of Gd-EOB-DTPA-enhanced MR imaging vs. extracellular contrast materials. Abdom Radiol (NY). 2020. PMID: 32248260. doi:10.1007/s00261-020-02511-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。